Melatonin synergizes BRAF-targeting agent vemurafenib in melanoma treatment by inhibiting iNOS/hTERT signaling and cancer-stem cell traits

Jiaojiao Hao, Wuguo Deng|Journal of Experimental & Clinical Cancer Research|2019

Cited by 55